PGC-1a controls mitochondrial biogenesis and dynamics in leadinduced neurotoxicity

Aging

Volumn 7, Issue 9, 2015, Pages 629-647

  Dabrowska, Aleksandra ^a   Venero, Jose Luis ^b   Iwasawa, Ryota ^a   Hankir, Mohammed khair ^c   Rahman, Sunniyat ^a   Boobis, Alan ^a   Hajji, Nabil ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SEVILLE   (Spain)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

BAP3; Calcium; Drp1; Lead; Mitochondrial biogenesis and dynamics; Neurotoxicity; PGC 1a

Indexed keywords

BAP31 PROTEIN, RAT; LEAD ACETATE; MEMBRANE PROTEIN; NEUROPROTECTIVE AGENT; ORGANOMETALLIC COMPOUND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

AGING; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL DEATH; CELL LINE; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; ENDOPLASMIC RETICULUM; GENETICS; LEAD POISONING; MITOCHONDRIAL DYNAMICS; ORGANELLE BIOGENESIS; PATHOPHYSIOLOGY; RAT; SIGNAL TRANSDUCTION;

AGING; ANIMALS; APOPTOSIS; CELL DEATH; CELL LINE; DOPAMINERGIC NEURONS; ENDOPLASMIC RETICULUM; LEAD POISONING, NERVOUS SYSTEM; MEMBRANE PROTEINS; MITOCHONDRIAL DYNAMICS; NEUROPROTECTIVE AGENTS; ORGANELLE BIOGENESIS; ORGANOMETALLIC COMPOUNDS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84943409597     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100790     Document Type: Article

References (40)

1. Austin S, St-Pierre J. PGC1alpha and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci. 2012; 125:4963-4971.
2. Uguccioni G, Hood DA. The importance of PGC-1alpha in contractile activity-induced mitochondrial adaptations. Am J Physiol Endocrinol Metab. 2011; 300:E361-71.
3. Sano M, Fukuda K. Activation of mitochondrial biogenesis by hormesis. Circ Res. 2008; 103:1191-1193.
4. Ojuka EO, Jones TE, Han DH, Chen M, Holloszy JO. Raising Ca2+ in L6 myotubes mimics effects of exercise on mitochondrial biogenesis in muscle. FASEB J. 2003; 17:675-681.
5. Su B, Wang X, Zheng L, Perry G, Smith MA, Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease. 2010; 1802:135-142.
6. Iwasawa R, Mahul-Mellier A, Datler C, Pazarentzos E, Grimm S. Fis1 and Bap31 bridge the mitochondria-ER interface to establish a platform for apoptosis induction. EMBO J. 2011; 30:556-568.
7. Steiner SR, Milton E, Philbert MA. A comparative study of protein carbonylation and mitochondrial dysfunction using the neurotoxicants 1, 3-dinitrobenzene, 3-nitropropionic acid, and 3-chloropropanediol. Neurotoxicology. 2013; 37:74-84.
8. Pissadaki EK, Bolam JP. The energy cost of action potential propagation in dopamine neurons: Clues to susceptibility in parkinson's disease. Frontiers in Computational Neuroscience. 2013; 7.
9. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nature Reviews Molecular Cell Biology. 2007; 8:870-879.
10. Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in parkinson's disease. Nature Reviews Neuroscience. 2006; 7:207-219.
11. O'Donnell KC, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A. Axon degeneration and PGC1a-mediated protection in a vertebrate model of a-synuclein toxicity. Disease Models & Mechanisms. 2014.
12. Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ. Mitochondrial loss, dysfunction and altered dynamics in huntington's disease. Hum Mol Genet. 2010; 19:3919-3935.
13. Stewart WF, Schwartz BS, Davatzikos C, Shen D, Liu D, Wu X, Todd AC, Shi W, Bassett S, Youssem D. Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology. 2006; 66:1476-1484.
14. Coon S, Stark A, Peterson E, Gloi A, Kortsha G, Pounds J, Chettle D, Gorell J. Whole-body lifetime occupational lead exposure and risk of parkinson's disease. Environ Health Perspect. 2006:1872-1876.
15. Weisskopf MG, Weuve J, Nie H, Saint-Hilaire M, Sudarsky L, Simon DK, Hersh B, Schwartz J, Wright RO, Hu H. Association of cumulative lead exposure with parkinson's disease. 2010.
16. Gurer-Orhan H, Sabir HU, Özgünes H. Correlation between clinical indicators of lead poisoning and oxidative stress parameters in controls and lead-exposed workers. Toxicology. 2004; 195:147-154.
17. Khan DA, Qayyum S, Saleem S, Khan FA. Lead-induced oxidative stress adversely affects health of the occupational workers. Toxicol Ind Health. 2008; 24:611-618.
18. Fan G, Zhou F, Feng C, Wu F, Ye W, Wang C, Lin F, Yan J, Li Y, Chen Y. Lead-induced ER calcium release and inhibitory effects of methionine choline in cultured rat hippocampal neurons. Toxicology in Vitro. 2013; 27:387-395.
19. Schaeffer PJ, Wende AR, Magee CJ, Neilson JR, Leone TC, Chen F, Kelly DP. Calcineurin and calcium/calmodulin-dependent protein kinase activate distinct metabolic gene regulatory programs in cardiac muscle. J Biol Chem. 2004; 279:39593-39603.
20. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003; 160:1115-1127.
21. Choi SW, Gerencser AA, Nicholls DG. Bioenergetic analysis of isolated cerebrocortical nerve terminals on a microgram scale: Spare respiratory capacity and stochastic mitochondrial failure. J Neurochem. 2009; 109:1179-1191.
22. Yadava N, Nicholls DG. Spare respiratory capacity rather than oxidative stress regulates glutamate excitotoxicity after partial respiratory inhibition of mitochondrial complex I with rotenone. J Neurosci. 2007; 27:7310-7317.
23. Katsouri L, Parr C, Bogdanovic N, Willem M, Sastre M. PPAR? co-activator-1a (PGC-1a) reduces amyloid-ß generation through a PPAR?-dependent mechanism. J Alzheimer's Dis. 2011; 25:151-162.
24. O'Donnell KC, Lulla A, Stahl MC, Wheat ND, Bronstein JM, Sagasti A. Axon degeneration and PGC-1alpha-mediated protection in a zebrafish model of alpha-synuclein toxicity. Dis Model Mech. 2014; 7:571-582.
25. Spiegelman BM. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. 2007; 287:60.
26. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, Handschin C, Zheng K, Lin J, Yang W. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006; 127:397-408.
27. Tapia PC. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients:"Mitohormesis" for health and vitality. Med Hypotheses. 2006; 66:832-843.
28. Ciron C, Lengacher S, Dusonchet J, Aebischer P, Schneider BL. Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function. Hum Mol Genet. 2012; 21:1861-1876.
29. Cartoni R, Leger B, Hock MB, Praz M, Crettenand A, Pich S, Ziltener JL, Luthi F, Deriaz O, Zorzano A, Gobelet C, Kralli A, Russell AP. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J Physiol. 2005; 567:349-358.
30. Martin OJ, Lai L, Soundarapandian MM, Leone TC, Zorzano A, Keller MP, Attie AD, Muoio DM, Kelly DP. A role for peroxisome proliferator-activated receptor gamma coactivator-1 in the control of mitochondrial dynamics during postnatal cardiac growth. Circ Res. 2014; 114:626-636.
31. Olanow C, Tatton W. Etiology and pathogenesis of parkinson's disease. Annu Rev Neurosci. 1999; 22:123-144.
32. Merrill RA, Dagda RK, Dickey AS, Cribbs JT, Green SH, Usachev YM, Strack S. Mechanism of neuroprotective mitochondrial remodeling by PKA/AKAP1. PLoS Biology. 2011; 9:e1000612.
33. Fan M, Rhee J, St-Pierre J, Handschin C, Puigserver P, Lin J, Jäeger S, Erdjument-Bromage H, Tempst P, Spiegelman BM. Suppression of mitochondrial respiration through recruitment of p160 myb binding protein to PGC-1alpha: modulation by p38 MAPK. Genes Dev. 2004; 1;18(3):278-89.
34. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit. 2006; 12:RA57-65.
35. Kern M, Audesirk G. Stimulatory and inhibitory effects of inorganic lead on calcineurin. Toxicology. 2000; 150:171-178.
36. Hernández-Fonseca K, Massieu L. Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons. J Neurosci Res. 2005; 82:196-205.
37. Chandra D, Choy G, Deng X, Bhatia B, Daniel P, Tang DG. Association of active caspase 8 with the mitochondrial membrane during apoptosis: Potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death. Mol Cell Biol. 2004; 24:6592-6607.
38. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol. 2003; 160:1115-1127.
39. Gundersen H, Bagger P, Bendtsen T, Evans S, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard J, Pakkenberg B. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988; 96:857-881.
40. Nelson JD, Denisenko O, Bomsztyk K. Protocol for the fast chromatin immunoprecipitation (ChIP) method. Nature Protocols. 2006; 1:179-185.